Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Stem Cell Therapeutics Corp. Announces Publication Of Phase I Stroke Data
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) is pleased to announce the acceptance and publication of the paper entitled "Open labeled, uncontrolled pharmacokinetic study of single intramuscular hCG dose in healthy male volunteers" by the International Journal of Clinical Pharmacology and Therapeutics, Vol. 47, August 2009. This paper was authored by Drs. Alan Moore, President & CEO, Allen Davidoff, VP Product Development and Yan Yang, Clinical Research Associate, all of SCT; Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and Dr. Steven C. Cramer, from the University of California, Irvine.

New Survey Shows Americans Strongly Support Guaranteed Dental Coverage In Healthcare Reform
Nearly 2 in 3 U.S. adults (63%) think that it is important that dental coverage is part of an overall health reform package, and 40 percent say it is very important, according to a new public opinion survey commissioned by Oral Health America. The survey, sponsored by the Dental Trade Alliance Foundation, and conducted by Harris Interactive(R), was released today at the launch of National Smile Month, the largest independent international campaign promoting good dental care including brushing, regular dental visits, and healthy food choices as well as the need for effective oral healthcare policies.
News of the day
Company Recalls Various Products Due To Potential Salmonella Contamination
Plainview Milk Products Cooperative, Plainview, Minn., is voluntarily recalling instant nonfat dried milk, whey protein, fruit stabilizers, and gums (thickening agents) that it has manufactured over the past two years, because they might be contaminated with Salmonella. The company sells these products to other industry customers, including distributors and manufacturers, who may have incorporated them into their own products. None of Plainview"s products were sold directly to the public.
Sexual Health

Komen Continues Grant Funding To Tissue Bank At Indiana University Simon Cancer Center

Researchers with the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center will continue their unique work thanks to a second $1 million grant from the Komen organization. Susan G. Komen for the Cure awarded this grant, enabling researchers to continue to collect and share healthy breast tissue samples with researchers worldwide to better understand how breast cells turn cancerous. Komen for the Cure provided an initial $1 million research grant to help start the tissue bank about one year ago. The tissue bank -- the nation"s first and only healthy breast tissue bank - currently has tissue from more than 450 women and blood samples from more than 4,500. "We are the only repository for this much normal tissue in the world," said Anna Maria Storniolo, M.D., co-principal investigator of the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center. "There"s no question that is a unique and incredibly precious re." Researchers from the Dana-Farber Cancer Institute and Walter Reed Medical Army Institute already are using specimens from the bank. "In breast cancer, in order to figure out what is abnormal, you have to be able to compare it to normal. Because of that, the normal controls from the Komen Tissue Bank are incredibly important," Storniolo said. "Research studies help us do more than develop new treatments. They also advance our understanding of how breast cancer develops in the first place, which can lead to new ways to detect or prevent the disease. This tissue bank is a unique opportunity for women to participate in and contribute to the research process," said Diana Rowden, vice president of Health Sciences for Komen for the Cure. By collecting blood and tissue from women with and without breast cancer, researchers will be able to determine the differences between these populations, which could lead to a better understanding of the disease. Blood and tissue samples taken from women without the disease are especially helpful because there are few collections of so-called "normal" specimens. In order to identify the changes cells undergo as they transition from normal to malignant, and to detect the earliest indication of malignant transformation, it"s vital to obtain and study "true normal" breast cells. Indiana University Simon Cancer Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009